APA (7th ed.) Citation

DN, E., VM, N., AL, R., S, W., Y, H., LC, K., . . . J, C. (2021). Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. The Journal of clinical investigation, 131(4), . https://doi.org/10.1172/JCI140100

Chicago Style (17th ed.) Citation

DN, Edwards, et al. "Selective Glutamine Metabolism Inhibition in Tumor Cells Improves Antitumor T Lymphocyte Activity in Triple-negative Breast Cancer." The Journal of Clinical Investigation 131, no. 4 (2021). https://doi.org/10.1172/JCI140100.

MLA (9th ed.) Citation

DN, Edwards, et al. "Selective Glutamine Metabolism Inhibition in Tumor Cells Improves Antitumor T Lymphocyte Activity in Triple-negative Breast Cancer." The Journal of Clinical Investigation, vol. 131, no. 4, 2021, https://doi.org/10.1172/JCI140100.